in serum in all cases of mucinous ovarian tumors and in some serous tumors (6). However, its concentrations may also be increased in bronchitis (3) and hepatobiliary obstruction (7). In patients with various nonmalignant gynecological disorders-including mild infections-TAT! concentrations are not increased (8). Patients with severe gynecological infections have not yet been studied. We now report a relatively high prevalence of high values for TAT! in serum of patients with proven P11), and a strong nonlinear correlation between TAT! and CRP.
TATI
values were increased in seven (24%), paralleling increases in CAP. TATI was increased by about 3.5-fold in seven of eight patients with CAP concentrations >90 mg/L, but in none of 21 patients with CAP concentrations <90 mg/L. TATI concentration and severity of PlO as determined by laparoscopy or endometrial biopsy were not correlated. These results suggest that, in severe infections, regulation of TATI synthesis resembles that of acute-phase proteins.
Microbial invasion, tissue injury, and acute inflammation turn on the acute-phase response in the host. During the response, the liver increases the synthesis of certain acutephase proteins.
Of these, C-reactive protein (CRP) is most widely measured in clinical practice.5 Acute pelvic inflammatory disease (Pifi) is a polymicrobial infection with a wide range of symptoms and signs. Determination of CRP in serum has hastened the diagnosis of P11) (1).
In a previous study (2) we demonstrated a high prevalence of above-normal concentrations of ovarian cancer antigen CA 125, but not of other tumor markers (CEA, AFP, CA 15-3, /32-microglobulin), in patients with proven P11).
Values for CA 125 were correlated with severity of PID, but not with CRP in serum. We have now studied the correlation between CRP and another marker for ovarian cancer, tumor-associated trypsin inhibitor (TATI) (3). TAT!, a 6-kDa peptide, is immunologically identical to the pancreatic secretory trypsin inhibitor (4, 5 in serum in all cases of mucinous ovarian tumors and in some serous tumors (6) . However, its concentrations may also be increased in bronchitis (3) and hepatobiliary obstruction (7) . In patients with various nonmalignant gynecological disorders-including mild infections-TAT! concentrations are not increased (8) . Patients with severe gynecological infections have not yet been studied. We now report a relatively high prevalence of high values for TAT! in serum of patients with proven P11), and a strong nonlinear correlation between TAT! and CRP. Collection of specimens. Collection of culture specimens for isolation of specific microorganisms from the vagina, cervix, and the upper tract was done as detailed elsewhere (9). Endometrial biopsy specimens were fixed in formalin and processed by routine histological methods. Sera were sampled at the time of admission and again at the time of discharge.
Materials and Methods

Study
Other procedures. 
Fisher's exact test was used for statistical comparisons.
Results
Of the 29 patients, 19 (66%) had supranormal values for serum CRP and seven (24%) had supranormal values for serum TAT!. CRP was increased in two (40%) of five patients with endometritis only, in seven (54%) of 13 patients with mild salpingitis, in six of seven patients with moderate salpingitis, and in all of four patients with severe salpingitis.
Values for CRP correlated positively with severity of proven P11) (Figure 1 CA 125, may become increased in benign gynecological conditions as well (13) (14) (15) . We now show that another marker for gynecological cancer, TAT!, may also become increased in severe gynecological infections.
However, the mechanisms behind the increases in these two markers may differ. origin is a part of the pathological mechanism in many infections, leading to dramatic increases in the synthesis of CRP (21) . In our patients, TAT! was never increased in connection with moderate increases in CRP. Evidently some additional factor, such as tumor necrosis factor (TNF), is required beforethe expressionof TAT! is increased. Induction of one protease inhibitor, a1-antichymotrypsin, in TNF-treated hepatocytes has been described (22). We have recently described a significant correlation between the concentrations in serum of another physiological protease inhibitor, a1-antitrypsin, and TAT! in pm patients (23) . However, the role of both IL-i and TNF as the primary inducers of the acute-phase response is still controversial (24). In P11) it is likely that: various lymphokines take part in the acute-phase response, their action is not synergistic, and there are complex interactions and feedback mechanisms.
Although theTAT! concentrations were clearly increased inpm during the acutephase, they normalized in allcases after the antimicrobial treatment.This was alsothecasefor CA 125 (2) . Although there was no correlation between TAT! and the severityof Pifi,increased concentration of TAT! seemed to predict tubal damage observed at second laparoscopy. This suggeststhat acute-phaseTAT! reflects tissue damage caused by severe inflammation, presumably associated with disruption of the basement membrane. Thus, healing of the inflammation by fibrosis might be more common in TATI-positive than in TATI-negative cases. However, larger prospective studies are needed to find out whether an increase in TAT! during the acute episode is a marker ofpermanent tubaldamage.
